Investigating Racial Differences in Diet Benefits for Knee Osteoarthritis
2 other identifiers
interventional
19
1 country
1
Brief Summary
Knee osteoarthritis (OA) is the most prevalent form of arthritis and race is a risk factor for poor outcomes. African-Americans (AAs) report greater OA-related disability and pain severity compared to their Non-Hispanic White (NHW) counterparts. These disparities are reinforced through social and biological mechanisms, ultimately resulting in dramatic racial disparities in pain experience and associated quality of life. Low-carbohydrate diets (LCDs) reduce inflammation and pain independent of weight loss, but significant racial differences exist in metabolism that are rarely addressed in diet interventions. The overall objective of the proposed study is to determine whether the beneficial effects of an LCD for knee OA pain are related to race. The investigators will recruit 20 adult women (65-75) with knee OA with equal representation across racial groups (10 AA, 10 NHW). Following one week of diet and pain self-report, the investigators will assess quality of life, depression, experienced pain and evoked pain. Participants will be placed on a LCD wherein all meals and snacks will be delivered weekly after consult with study personnel. Participants will return every 3 weeks for testing during the 6-week intervention with blood drawn at baseline and at the conclusion of the 6-week diet. Blood will be assayed for oxidative stress markers. This will be the first assessment of racial differences in the efficacy of a LCD to reduce knee OA pain. Objective 1: To determine whether the LCD reduces pain after 6 weeks. Hypothesis: The LCD will significantly reduce evoked and self-reported pain. Objective 2: To determine whether the benefits of the LCD differ based on race. Hypothesis 1: The LCD will reduce evoked and self-reported pain more in AA than in NHW. Hypothesis 2: AAs will experience greater improvements in depression, quality of life, pain interference and show more weight loss than NHWs. Objective 3: To determine whether the LCD has a differential impact on oxidative stress by race. Hypothesis 1: The LCD will significantly reduce oxidative stress over 6 weeks. Hypothesis 2: AAs will show greater reductions in oxidative stress than NHWs. The reduction in oxidative stress will be correlated with reduction in evoked pain.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable knee-osteoarthritis
Started Oct 2020
Longer than P75 for not_applicable knee-osteoarthritis
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 6, 2020
CompletedFirst Posted
Study publicly available on registry
April 13, 2020
CompletedStudy Start
First participant enrolled
October 1, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 18, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
September 18, 2023
CompletedResults Posted
Study results publicly available
January 9, 2025
CompletedJanuary 9, 2025
December 1, 2024
3 years
April 6, 2020
September 16, 2024
December 31, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
WOMAC Pain Change
The Western Ontario and McMaster Osteoarthritis Index (WOMAC) pain score is a 0-20 score with higher scores reflecting more severe pain. Questions 1-5 are summed to provide a WOMAC pain score. Change scores will be calculated. The week 6 WOMAC pain subscale score was subtracted from the baseline score to obtain a difference score. Numbers closer to zero indicate no change.
Baseline (week 0), immediately after the intervention (6 weeks)
BPI Pain Change
The Brief Pain Inventory (BPI) pain score is a 0-40 score with higher scores reflecting more pain. Questions 3-6 are scored on 0-10 and are summed to provide an overall pain score. The week 6 score was subtracted from the baseline score to obtain a difference score. Numbers closer to zero indicate no change.
Baseline (week 0), immediately after the intervention (6 weeks)
Secondary Outcomes (5)
WOMAC Physical Function
Baseline (week 0), immediately after the intervention (6 weeks)
BPI Pain Interference Change
Baseline (week 0), immediately after the intervention (6 weeks)
TS Pain Intensity Change
Baseline (week 0), immediately after the intervention (6 weeks)
RCS Pain Intensity Change
Baseline (week 0), immediately after the intervention (6 weeks)
PHQ-9 Depression Change
Baseline (week 0), immediately after the intervention (6 weeks)
Other Outcomes (5)
RCS Time to Completion Change
Baseline (week 0), immediately after the intervention (6 weeks)
TW Pain Intensity Change
Baseline (week 0), immediately after the intervention (6 weeks)
TW Time to Completion Change
Baseline (week 0), immediately after the intervention (6 weeks)
- +2 more other outcomes
Study Arms (2)
White women
EXPERIMENTALWhite women aged 65-75 with knee OA
Black women
EXPERIMENTALBlack women aged 65-75 with knee OA
Interventions
A diet low in daily carbohydrates (\<40 grams/day) provided as prepared meals.
Eligibility Criteria
You may qualify if:
- diagnosis of knee OA
- pain in at least 4/7 days/week for the past 3 months
- age between 65-75
- average daily consumption of \>100 g carbohydrates
- understanding of verbal and written English
- self-identification as either AA or NHW
- BMI between 25 and 40 kg/m2
You may not qualify if:
- diabetes
- unwillingness to follow prescribed diets
- recent weight change (\>4 kg in past month)
- currently on a diet
- history of eating disorders or other psychiatric disorders
- digestive diseases
- difficulty chewing or swallowing
- reliance on others for meal preparation
- cardiovascular or pulmonary disease
- daily opioid pain medications
- use of medications known to alter metabolism or digestion (e.g., proton-pump inhibitors)
- use of anti-hypertensive medications that affect glucose tolerance
- use of tobacco
- participation in extreme exercise
- knee replacement
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Alabama at Birmingham
Birmingham, Alabama, 35294, United States
Related Publications (2)
Strath LJ, Jones CD, Philip George A, Lukens SL, Morrison SA, Soleymani T, Locher JL, Gower BA, Sorge RE. The Effect of Low-Carbohydrate and Low-Fat Diets on Pain in Individuals with Knee Osteoarthritis. Pain Med. 2020 Jan 1;21(1):150-160. doi: 10.1093/pm/pnz022.
PMID: 30865775RESULTWiggins AM, Strath LJ, McPherson GE, Gower BA, Goss AM, Goodin BR, Sorge RE. The effect of a low-carbohydrate diet on evoked pain and quality of life in Non-Hispanic black women with knee osteoarthritis: a pilot study. BMC Musculoskelet Disord. 2024 Dec 19;25(1):1043. doi: 10.1186/s12891-024-08170-x.
PMID: 39702235DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Limitations and Caveats
This was a pilot study with a small sample size. Due to recruiting issues around the pandemic and after, we were not able to recruit NWH women into the study in numbers to allow for our planned analyses. Thus, the resulting investigation was determined to be focused on NHB women and assessed as pre-post analyses. Blood samples were not taken, so physiological measures were not possible.
Results Point of Contact
- Title
- Dr. Robert Sorge
- Organization
- University of Alabama at Birmingham
Study Officials
- PRINCIPAL INVESTIGATOR
Robert E Sorge, PhD
University of Alabama at Birmingham
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
April 6, 2020
First Posted
April 13, 2020
Study Start
October 1, 2020
Primary Completion
September 18, 2023
Study Completion
September 18, 2023
Last Updated
January 9, 2025
Results First Posted
January 9, 2025
Record last verified: 2024-12
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP
- Time Frame
- For 5 years following final data analysis
- Access Criteria
- De-identified data can be made available on encrypted servers for researchers whose research plans do not overlap with the aims of the current project. Requests will be assessed by the PI and Co-Is as needed.
Following our extended analysis period, de-identified data will be made available, as well as the variable key, to the scientific community. Before this time, a request for data sharing will be assessed by study personnel (PI and Co-Is) as needed. These requests will be evaluated based on scientific merit and overlap with the aims of the current study.